OPHLY – ono pharm co unsp/adr (US:NASDAQ)

News

Shattuck plunges after discontinuing lead candidate [Seeking Alpha]
U.S. Food and Drug Administration Accepts for Priority Review Deciphera's New Drug Application for Vimseltinib for the Treatment of Patients with Tenosynovial Giant Cell Tumor (TGCT) [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com